People

Maurizio Fava

Maurizio Fava

Maurizio Fava serves as Scientific Advisory Board Member at Newleos Therapeutics, a clinical-stage neuroscience company. Maurizio Fava MD is a published external PureTech collaborator and executive vice chair of psychiatry and director of the clinical trials network and institute at Massachusetts General Hospital. His existing Newleos scientific advisory identity and portrait are preserved.

Roles

Damona Pharmaceuticals

Scientific Advisory Board Member

Current
Newleos Therapeutics

Scientific Advisory Board Member

Current
Iaso Ventures

Advisor, Clinical R&D

Current
Sensorium Therapeutics

Scientific and Clinical Advisor

Current
PureTech Health

Scientific Collaborator (external; published network)

Current
Click Therapeutics

Scientific Advisor

Current
Dolby Family Ventures

Scientific Advisory Board Member

Current